Page last updated: 2024-11-03

propranolol and Arrhythmogenic Right Ventricular Dysplasia

propranolol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kriebel, T1
Korte, T1
Kandolf, R1
Jux, C1
Windhagen-Mahnert, B1
Bökenkamp, R1
Bertram, H1
Paul, T1

Other Studies

1 other study available for propranolol and Arrhythmogenic Right Ventricular Dysplasia

ArticleYear
[Arrhythmogenic right ventricular dysplasia/cardiomyopathy - diagnosis in childhood].
    Zeitschrift fur Kardiologie, 2003, Volume: 92, Issue:5

    Topics: Adolescent; Adult; Age Factors; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia;

2003